News from galectin therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jul 24, 2013, 08:30 ET Galectin Therapeutics Announces First Patient Dosed in Phase 1 Trial of GR-MD-02, a Potential First-in-Class Treatment for Fatty Liver Disease with Advanced Fibrosis

Galectin Therapeutics (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced...


Jul 01, 2013, 08:00 ET Galectin Therapeutics Submits Fast Track Application to FDA for GR-MD-02 in Treatment of Fatty Liver Disease with Advanced Fibrosis

Galectin Therapeutics (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced...


Jun 21, 2013, 08:00 ET Galectin Therapeutics Names Industry-Veteran Jack W. Callicutt Chief Financial Officer

Galectin Therapeutics (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today...


May 23, 2013, 09:16 ET Galectin Therapeutics to Hold Conference Call to Provide Update Following Company's Annual Meeting of Shareholders -- New Phone Number for Audio Portion of Presentation

Galectin Therapeutics (NASDAQ: GALT) will host a conference call at 9:30 A.M. Eastern Time on Thursday, May 23, 2013, to provide an update following...


May 15, 2013, 08:00 ET Galectin Therapeutics to Hold Conference Call to Provide Update Following Company's Annual Meeting of Shareholders

Galectin Therapeutics (NASDAQ: GALT) will host a conference call at 9:30 A.M. Eastern Time on Thursday, May 23, 2013, to provide an update following...


Apr 29, 2013, 08:00 ET Galectin Inhibitors Reverse Liver Cirrhosis in Preclinical Studies

Galectin Therapeutics (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today...